Pulmonary Valve Insufficiency: Clinical Trials

1 recruiting. 1 Phase 4.

By phase and status

Phase	Trials	Status
Phase 4	1	Recruiting 1

Follow Pulmonary Valve Insufficiency: new trials by email Literature Review of Pulmonary Valve Insufficiency trials Research Report on Pulmonary Valve Insufficiency

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
Sodium-Glucose Cotransporter 2 Inhibitors for Repaired Tetralogy of Fallot Patients for Enhancement of Cardio-Pulmonary Status Trial SGLT2 inhibitor (Dapagliflozin 10mg) - Congenital Heart Disease, Repaired Tetralogy of Fallot (rTOF)	Phase 4	Recruiting	The University of Hong Kong	106	2025-05-12	2025-05-20

Narrower conditions

Heart Defects, Congenital (1)

Broader conditions

Cardiovascular Abnormalities (1)  ·  Cardiovascular Diseases (1)  ·  Congenital Abnormalities (1)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Heart Diseases (1)  ·  Heart Valve Diseases (1)

Interventions

Sodium-Glucose Transporter 2 Inhibitors (1)  ·  dapagliflozin (1)

Sponsors

The University of Hong Kong (1)

Countries

Hong Kong (1)

Top investigators

Chun-Ka Dr Wong, Clinical Assistant Professor (1)

Results publications

PMID 17572925, PMID 20970202, PMID 26114442, PMID 29222139, PMID 29663436, PMID 31351553, PMID 31535829, PMID 31980166, PMID 33197559, PMID 34405863, PMID 34656466, PMID 35487320, PMID 36171554, PMID 36605072, PMID 37435053, PMID 37615988, PMID 37622666, PMID 38162132, PMID 38430085